Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1980-1-19
|
pubmed:abstractText |
Twenty-four patients with inoperable lung carcinoma other than of the small cell type who received cis diamminedichloro platinum (II)-based combination chemotherapy were further treated with all available treatment modalities: radiation therapy, lung resection, chemotherapy, and immunotherapy. There were 2 operative deaths, and 2 patients died 6 and 8 months postoperatively of cardiac causes. Postmortem examination on these 4 patients revealed no evidence of residual tumor. The remaining 20 patients are alive 7 to 33 months from the onset of chemotherapy and 4 to 27 months following lung resection. These results, although preliminary, are encouraging, and further study is in progress.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0003-4975
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:507983-Adenocarcinoma,
pubmed-meshheading:507983-Adult,
pubmed-meshheading:507983-Aged,
pubmed-meshheading:507983-Antineoplastic Agents,
pubmed-meshheading:507983-Carcinoma, Squamous Cell,
pubmed-meshheading:507983-Cisplatin,
pubmed-meshheading:507983-Drug Therapy, Combination,
pubmed-meshheading:507983-Female,
pubmed-meshheading:507983-Humans,
pubmed-meshheading:507983-Immunotherapy,
pubmed-meshheading:507983-Lung Neoplasms,
pubmed-meshheading:507983-Male,
pubmed-meshheading:507983-Middle Aged
|
pubmed:year |
1979
|
pubmed:articleTitle |
Treatment of inoperable lung carcinoma: a combined modality approach.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|